Risk | Low |
Patch available | NO |
Number of vulnerabilities | 1 |
CVE-ID | CVE-2020-10597 |
CWE-ID | CWE-284 |
Exploitation vector | Local |
Public exploit | N/A |
Vulnerable software Subscribe |
Omnipod Insulin Management System Client/Desktop applications / Other client software |
Vendor | Insulet Corporation |
Security Bulletin
This security bulletin contains one low risk vulnerability.
EUVDB-ID: #VU26245
Risk: Low
CVSSv3.1: 6.7 [CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L/E:U/RL:U/RC:C]
CVE-ID: CVE-2020-10597
CWE-ID:
CWE-284 - Improper Access Control
Exploit availability: No
DescriptionThe vulnerability allows a local attacker to gain unauthorized access to otherwise restricted functionality.
The vulnerability exists due to improper access restrictions in the wireless RF communication protocol. A local attacker with access to one of the affected insulin pump models can bypass implemented security restrictions and modify and/or intercept data.
The vulnerability can also allow attackers to change pump settings and control insulin delivery.
This vulnerability affects the following versions of the Omnipod Insulin Management System:
Cybersecurity Help is currently unaware of any official solution to address this vulnerability.
Vulnerable software versionsOmnipod Insulin Management System: All versions
External linkshttp://ics-cert.us-cert.gov/advisories/icsma-20-079-01
Q & A
Can this vulnerability be exploited remotely?
No. This vulnerability can be exploited locally. The attacker should have authentication credentials and successfully authenticate on the system.
Is there known malware, which exploits this vulnerability?
No. We are not aware of malware exploiting this vulnerability.